Delivery Order SPE2DB22D2009-SPE2DB24FL9RE

Award Date 5/13/24
Potential Completion Date 5/14/24
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $1,388.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 13, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,241.34 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which runs through June 2024, is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, is providing these products to support DLA Troop Support Medical's mission to procure...
The U.S. Defense Logistics Agency (DLA) awarded a $1,483.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $4,569.04 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a specialty medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $6,322.56 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of May 21, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a $3,687.28 firm-fixed-price delivery order contract to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,270.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564261561 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there was no set-aside designation used for this award. This delivery order is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $1,393.14 firm fixed-price contract is for the supply of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML." This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which enables DLA to efficiently...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,986.80 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4564668271 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, with a completion date of May 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $15,271.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of May 30, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL9RE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen's expertise in pharmaceutical distribution and extensive supply chain network allow it to efficiently fulfill government medical product requirements for the Department of Defense and other federal agencies.

Generated 8/12/24, 9:36 AM